首页> 外文OA文献 >P2.03-22 OCT4andSOX2 Specific CTLs Plus PD-1 Inhibitor Had Synergistic Effect on Killing CSC And Treating Drug-Resistant Lung Cancer Mice

【2h】

P2.03-22 OCT4andSOX2 Specific CTLs Plus PD-1 Inhibitor Had Synergistic Effect on Killing CSC And Treating Drug-Resistant Lung Cancer Mice

机译：P2.03-22 Oct4Ard4AdsOx2特异性CTLS加上PD-1抑制剂对杀害CSC和治疗耐药性肺癌小鼠具有协同作用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
X. Zhang; F. Hu; X. Zheng; B. Zhang; H. Wang; G. Tao; J. Xu; Y. Zhang; B. Han;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. P2.03-22 OCT4andSOX2 Specific CTLs Plus PD-1 Inhibitor Had Synergistic Effect on Killing CSC And Treating Drug-Resistant Lung Cancer Mice [J] . X. Zhang, F. Hu, X. Zheng, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2018,第10期

机译：P2.03-22 Oct4Ard4AdsOx2特异性CTLS加上PD-1抑制剂对杀害CSC和治疗耐药性肺癌小鼠具有协同作用
2. Synergistic Anticancer Activity of Topotecan— Cyclin-Dependent Kinase Inhibitor Combinations against Drug-Resistant Small Cell Lung Cancer (SCLC) Cell Lines [J] . Gerhard Hamilton, Ulrike Olszewski Lukas Klameth, Ernst Ulsperger, Journal of Cancer Therapy . 2013,第8期

机译：拓扑替康—细胞周期蛋白依赖性激酶抑制剂组合对耐药小细胞肺癌（SCLC）细胞系的协同抗癌活性
3. Killing time for cancer stem cells (CSC): discovery and development of selective CSC inhibitors. [J] . Perez Caro M, Sanchez Garcia I Current medicinal chemistry . 2006,第15期

机译：杀死癌症干细胞（CSC）的时间：发现和开发选择性CSC抑制剂。
4. PHOSPHOPROTEOMICS OF NON-SMALL-CELL LUNG CANCER CELLS TREATED WITH ERLOTINIB REVEALS DRUG-RESISTANT SIGNATURES AND POTENTIAL TARGETS [C] . Jun Adachi, Yuichi Abe, Maiko Nagano, International Mass Spectrometry Conference . 2018

机译：用厄洛替尼处理的非小细胞肺癌细胞的磷脂蛋白酶揭示了耐药象征和潜在目标
5. Cystargolide-Inspired Proteasome Inhibitors for Treating Cancer: Killing Cancerous Cells or Altering Intercellular Communication [D] . Hallada, Liam P. 2018

机译：Cystargolide启发的蛋白酶体抑制剂治疗癌症：杀死癌细胞或改变细胞间通讯
6. Human Papillomavirus Type 16 (HPV-16) Virus-Like Particle L1-Specific CD8+ Cytotoxic T Lymphocytes (CTLs) Are Equally Effective as E7-Specific CD8+ CTLs in Killing Autologous HPV-16-Positive Tumor Cells in Cervical Cancer Patients: Implications for L1 Dendritic Cell-Based Therapeutic Vaccines [O] . Stefania Bellone, Karim El-Sahwi, Emiliano Cocco, 2009

机译：人乳头瘤病毒16型（HPV-16）病毒样L1特异性CD8 +细胞毒性T淋巴细胞（CTL）与E7特异性CD8 + CTL一样有效地杀死宫颈癌患者的自体HPV-16阳性肿瘤细胞：对L1的影响基于树突状细胞的治疗疫苗
7. Synergistic Anticancer Activity of Topotecan— Cyclin-Dependent Kinase Inhibitor Combinations against Drug-Resistant Small Cell Lung Cancer (SCLC) Cell Lines [O] . Gerhard Hamilton, Ulrike Olszewski, Lukas Klameth, Ernst Ulsperger, 2013

机译：拓扑替康—细胞周期蛋白依赖性激酶抑制剂组合对耐药小细胞肺癌（SCLC）细胞系的协同抗癌活性

P2.03-22 OCT4andSOX2 Specific CTLs Plus PD-1 Inhibitor Had Synergistic Effect on Killing CSC And Treating Drug-Resistant Lung Cancer Mice

著录项

引文网络

相似文献

相关主题

期刊订阅